Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Rosuvastatin/Ezetimibe for NAFLD
NCT03434613Phase 4Completed
- Sponsor
- Yonsei University
- Start
- May 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in non-alcoholic fatty liver disease (NAFLD), sponsored by Yonsei University. Started May 2018; status: completed.
02
Drugs
ezetimibe
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT03434613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03434613.